Related Experiment Video

Updated: Apr 28, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.0K

Probenecid reduces infection and inflammation in acute Pseudomonas aeruginosa pneumonia

Bodo Wonnenberg1, Thomas Tschernig2, Meike Voss1

  • 1Department of Internal Medicine V - Pulmonology, Allergology and Respiratory Critical Care Medicine, Saarland University, Homburg, Germany.

International Journal of Medical Microbiology : IJMM
|June 19, 2014
PubMed

Insights

Probenecid, an inhibitor of Pannexin-1 (Px1) channels, reduces Pseudomonas aeruginosa infection and inflammation. This drug improves bacterial clearance and lowers inflammatory mediators in acute lung infections.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • Inflammasome activation drives acute Pseudomonas aeruginosa pneumonia pathology.
  • Pannexin-1 (Px1) channels are crucial for inflammasome activation and IL-1β release.
  • P2X7 receptor activation initiates Px1 channel activity and subsequent inflammation.

Purpose of the Study:

  • To investigate the therapeutic potential of probenecid, a Px1 inhibitor, in acute P. aeruginosa pneumonia.
  • To determine if probenecid can reduce bacterial load and inflammation in a mouse model.
  • To assess probenecid's effect on inflammatory mediator release in macrophages and epithelial cells.

Main Methods:

  • Treatment of mice with probenecid prior to P. aeruginosa infection.
  • Quantification of bacterial clearance and inflammatory mediator levels (e.g., IL-1β).
  • In vitro studies on murine alveolar macrophages, human U937-derived macrophages, and human bronchial epithelial cells.

Main Results:

  • Probenecid treatment significantly enhanced P. aeruginosa clearance in mice.
  • Reduced levels of inflammatory mediators, including IL-1β, were observed in probenecid-treated mice.
  • Probenecid inhibited inflammatory mediator release in macrophages but not in bronchial epithelial cells.

Conclusions:

  • Pannexin-1 (Px1) blockade with probenecid demonstrates therapeutic potential for P. aeruginosa pneumonia.
  • Probenecid improves bacterial clearance and mitigates harmful inflammation.
  • Targeting Px1 channels offers a promising strategy for managing P. aeruginosa lung infections.
Keywords:
HyperinflammationInfectionInflammationPannexin-1PneumoniaProbenecid

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

17.4K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

10.5K

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
832
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
944